Chimeric Therapeutics Begins Landmark Cancer Trial

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics has launched a Phase 1/2 clinical trial for its innovative CHM CD...

Related Keywords

,Chimeric Therapeutics Ltd ,Chimeric Therapeutics ,